Connection

AYSE MINDIKOGLU to Liver Transplantation

This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Liver Transplantation.
Connection Strength

2.642
  1. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci. 2016 Jan; 61(1):309-16.
    View in: PubMed
    Score: 0.272
  2. Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014 Jan-Feb; 46(1):219-24.
    View in: PubMed
    Score: 0.241
  3. Impact of estimated liver volume and liver weight on gender disparity in liver transplantation. Liver Transpl. 2013 Jan; 19(1):89-95.
    View in: PubMed
    Score: 0.224
  4. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012 Apr; 25(4):409-15.
    View in: PubMed
    Score: 0.211
  5. Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc. 2011 Sep; 43(7):2669-77.
    View in: PubMed
    Score: 0.205
  6. Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J Pediatr. 2011 May; 158(5):802-7.
    View in: PubMed
    Score: 0.195
  7. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010 Oct; 16(10):1147-57.
    View in: PubMed
    Score: 0.193
  8. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009 Jul; 15(7):719-29.
    View in: PubMed
    Score: 0.177
  9. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008 Feb 15; 85(3):359-68.
    View in: PubMed
    Score: 0.161
  10. Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization. J Gastroenterol. 2005 Mar; 40(3):302-5.
    View in: PubMed
    Score: 0.131
  11. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019 12; 19(12):3299-3307.
    View in: PubMed
    Score: 0.089
  12. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.085
  13. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.083
  14. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.080
  15. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.079
  16. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 02; 16(2):162-177.e1.
    View in: PubMed
    Score: 0.077
  17. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.076
  18. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009 Dec; 15(12):1814-20.
    View in: PubMed
    Score: 0.045
  19. Renal dysfunction in cirrhosis. Curr Opin Gastroenterol. 2015 May; 31(3):215-23.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.